Professional Documents
Culture Documents
10 1016@j Obmed 2019 100169
10 1016@j Obmed 2019 100169
10 1016@j Obmed 2019 100169
PII: S2451-8476(19)30089-2
DOI: https://doi.org/10.1016/j.obmed.2019.100169
Reference: OBMED 100169
Please cite this article as: Sharafi, S.E., Garmaroudi, G., Ghafouri, M., Bafghi, S.A., Ghafouri, M.,
Tabesh, M.R., Alizadeh, Z., Prevalence of anxiety and depression in patients with overweight and
obesity, Obesity Medicine, https://doi.org/10.1016/j.obmed.2019.100169.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
Sayedeh Elham Sharafi, Psychosomatic research center, Imam Khomeini Hospital, Tehran University of
Medical Science, Tehran, Iran
esharafi@yahoo.com, Tell: +98(21)88630227-8, Fax: +98(21)88003539
Gholamreza Garmaroudi, School of Public Health, Tehran University of Medical Sciences, Tehran,
Iran.
garmaroudi@tums.ac.ir, Tell: +98(21)88630227-8, Fax: +98(21)88003539
Mohammad ghafouri, School of medicine, Tehran University of Medical Sciences, Tehran, Iran
Mohammadghafouri1372@gmail.com, Tell: +98(21)88630227-8, Fax: +98(21)88003539
Shabnam akhoundzadeh bafghi, School of Medicine, Shahid Sadoughi university of Medical Sciences,
Yazd, Iran.
Shabnam21219@yahoo.com, Tell: +98(21)88630227-8, Fax: +98(21)88003539
Mojtaba ghafouri, School of Medicine and Public Health, Tehran University of Medical Sciences,
Tehran, Iran
Ghafouri_mojtaba@yahoo.com, Tell: +98(21)88630227-8, Fax: +98(21)88003539
Mastaneh Rajabian Tabesh, Sports Medicine Research Center, Tehran university of Medical Sciences,
Tehran, Iran.
mastaneh.tabesh@ut.ac.ir, Tell: +98(21)88630227-8, Fax: +98(21)88003539
1. Sports Medicine Research Center, Tehran university of Medical Sciences, Tehran, Iran.
2. Department of Sports and Exercise Medicine, Tehran University of Medical Sciences, Tehran,
Iran.
Address: No7, Ale-ahmad Highway, Opposite of the Shariati Hospital, 14395-578, Tehran, Iran
Abstract:
Aim: Depression and anxiety are the most common psychological disorders among obese
patients. Therefore, understanding the risk factors for this relationship is essential. This study
was carried out aiming to assess the association of anxiety and depression with BMI and to
Methods: This cross-sectional study was conducted on a large sample of 732 overweight and
obese patients. Hospital Anxiety and Depression Scale (HADS) questionnaire was used for
measuring depression and anxiety. Additionally, for all subjects, body mass index (BMI),
percentage of body fat (PBF) and total soft lean mass (SLM) were measured using AVIS 33
Results: We found that BMI and PBF were significantly higher among overweight/obese
patients who had anxiety or depression. Depression and anxiety were more frequent among
housekeepers. Anxiety (p<0.001) and depression (P<0.001) scores were also positively
correlated with BMI but not with PBF and SLM in different groups of BMI. Female subjects had
a higher prevalence of anxiety (p=0.010). In addition, sleep hours did not have correlated with
symptoms irrespective of sleep behavior. On the other hand, depression and anxiety were found
to be the potential risk factors for developing obesity. These results indicate a direct association
Introduction
The prevalence of obesity and overweight is increasing rapidly and reaching an alarming rate
worldwide (Sturm 2007). In Iran, 61.6% of the adult population were overweight and 25.8%
were obese in 2016 (World Health Organisation 2019). It is evident that overweight and obesity
are associated with several comorbidities including diabetes, cardiovascular disease, some type
of cancer, and psychiatric disorders which negatively influence the quality of life (Onyike et al.
2003; Flegal et al. 2005). Depression and anxiety are two of the most common psychiatric
There are numerous data that link obesity to depressive and anxiety symptoms (Preiss et al.
2013; Luppino et al. 2010; Kalarchian and Marcus 2012; Pan et al. 2012); however, there are
some controversies surrounding this association. Some previous studies suggest that body fat
distribution and sleep behavior were a stronger risk factors for this correlation (Moreira et al.
2007; Labad et al. 2010; Whitaker et al. 2018). Additionally, it has been shown that total lean
mass was strongly associated with fewer anxiety/depressive symptoms. Thus, body composition
comprising fat and lean tissue might be related to psychiatric comorbidity in overweight
individuals (Guedes et al. 2013). There were also recognized racial-ethnic differences in body
composition (Sun et al. 2003) which could influence the mentioned association. While to our
knowledge, there has not been a study investigating the association of body composition with the
several physical illnesses which may influence measuring depression and anxiety. Hence, using
suitable evaluation method such as HADS1 questionnaire with the emphasis on reducing the
impact of physical illness on the total score is more competent (Edelstein et al. 2010). Therefore,
1
Hospital Anxiety and Depression Scale
4
the aim of this study was to evaluate the prevalence of anxiety and depression using HADS in
This cross-sectional study was conducted on patients with overweight and obesity BMI 2≥ 25,
who referred to the Obesity Clinic in Imam Khomeini Hospital, Tehran, Iran; from April 2016 to
January 2016. Inclusion criteria consisted of all age groups of patients with overweight and
obesity, who referred to the clinic, signed a consent form to participate in the study, and had the
ability of reading and writing. Exclusion criteria consisted of young children and the elderly who
have difficulty understanding the questionnaire, people who did not have the ability to read and
write (according to the self-report questionnaire), and patient's dissatisfaction to enter the study.
Participants
Seven hundred fifty patients with BMI≥25, based on inclusion criteria were included. Eighteen
patients excluded due to incomplete data (ten patients), disability to read and write (six patients),
and have difficulty to understand the questionnaire (two patients). Finally, 732 patients
completed the study. The study received ethics approval from the Ethics Committee of Tehran
completed informed consent. A demographic questionnaire including age, sex, occupation, sleep
hours and HADS questionnaire for depression and anxiety were completed. For all subjects,
2
Body mass index
5
BMI, PBF3 and total SLM4 were measured using AVIS 33 body composition analyzer and all of
Instrument
AVIS 33 body composition analyzer: The AVIS 33 body composition analyzer was used to
measure body composition. Using this device through the BIA5 method, all body composition
were measured including BMI, PBF, and SLM. The accuracy of the BIA method for measuring
body composition has been confirmed in various studies (Beshyah et al. 1995; Earthman et al.
Hospital Anxiety Depression Scale (HADS): This 14 items questionnaire is a short form
questionnaire which evaluates the anxiety and depression by removing the physical symptoms
and focusing on psychological signs and symptoms. This questionnaire evaluates two subscales
including anxiety and depression. Scores for each subscale (anxiety and depression) range from 0
to 21 with scores categorized as follows: normal 0-7, suspicious 8-10, and the presence of a
depressive or anxiety disorder 11-21. The HADS has been found to be a reliable questionnaire in
psychiatric, non-psychiatric and well populations (Bjelland et al. 2002). The psychometric
properties of the Persian version of the scale was examined. In a study of Iranian patients,
Cronbach's alpha coefficient for depression and anxiety subscales were 0.78 and 0.86,
respectively (Nejat et al. 2006). Obesity is usually accompanied by several physical illnesses
which may influence measuring depression and anxiety. While using the HADS which emphasis
3
percentage body fat
4
soft lean mass
5
bioelectrical impedance analysis
6
on reducing the impact of physical illness on the total score, rises the validity of the current study
Data analysis
Data were analyzed and reported only for patients with completed information. Statistical
analysis of data was performed using SPSS version 18 software. Chi-square test was used to
compare qualitative variables between groups. Kolmogorov-Smirnov test was used in order to
evaluate the normal distribution of all quantitative studied parameters. Student t-test was used for
variables with normal distribution, on the other hand, Mann-Whitney and Wilcoxon tests were
used for variables without normal distribution. The two-tailed p-value less than 0.05 was
considered significant.
Results
The mean depression score in the studied population was 6.78 ±3.9 (0-21) and the anxiety score
was 7.79 ±4.9 (0-21). The prevalence of depression among all the study population was 17.5 %
(n= 128; 3% in overweight and 14.3% in obese patients) and 23.8% (n=178; 5.9% in overweight
and 17.9% in obese patients) were suspicious to have depression. Moreover, the prevalence of
anxiety was 26.5 % (n= 194; 7.4% in overweight and 19.1% in obese patients) while 22%
(n=161; 5.9% in overweight and 16.1% in obese patients) were suspected to have anxiety.
As obtained, age in obese patients with anxiety was significantly higher than other patients
(P=0.045). Interestingly, the anxiety score was significantly higher in women compared to men
(28.4 % vs 17.5%; P=0.04) (Table 1). While there was no significant difference in depression
score between two sex (P>0.05) (Table 2). Moreover, we found that BMI and PBF were
significantly higher in patients with anxiety and depression as compared to normal and
7
suspicious patients and the SLM was higher among depressed cases as well as suspicious to
anxiety (P<0.05). Furthermore, we found that anxiety was significantly higher in housekeeper
patients (P=0.002). This difference was obtained in patients with depression that depression was
As shown in table 3 neither anxiety nor depression have any significant correlation with sleep
hours (P= 0.37 and 0.49, respectively). Logistic regression analyses were used for comparative
and moderator analyses of age, BMI, PBF, and SLM on HADS scores. We found that only BMI
was positively correlated with depression (P<0.001, Exp (B) = 0.169) and anxiety (P=0.001, Exp
(B) = 0.126) development among the study groups. Thus, the positive correlation of PBF (r=
0.194, P<0.001) and SLM (r=0.096, P=0.01) with depression score and PBF (r= 0.175, P<0.001)
Regarding the non-normality of the data distribution, the Mann-Whitney U test was used to
compare males and females. In this regard, the result shows that there was a significant
difference in the anxiety scores (Z= -2.565, p=0.001) between males and females, but this
difference was not significant in depression scores (Z= -0.538, p=0.590). The Kruskal Wallis
test was used to compare the anxiety and depression scores for occupation and BMI and Tables 5
In table 5, The finding indicates that there was a significant difference in the anxiety (χ²= 16.564,
df=3, p=0.001) and depression (χ²=35.574, df=3, 0.001) scores between occupations. Mean and
mean rank showed that housekeepers had a higher rate of anxiety and depression.
8
Our result in BMI (table 6) showed that there was a significant difference in the anxiety (χ²=
16.904, df=3, p=0.001) and depression (χ²=45.447, df=3, 0.001) scores between BMI categories.
Mean and mean rank showed that 40 ≤ categories had a higher rate of anxiety and depression.
Discussion
Association between Overweight/ obesity and anxiety/ depression: Our results showed that
the average BMI and PBF were significantly higher in patients suffering from anxiety or
depression. On the other hand, the results from logistic regression analysis demonstrated that
BMI was positively correlated with anxiety and depression, as the BMI rises the HADS score
increases. It has been estimated that in Iran, about 61.6% of the adult population suffers from
findings (Emamian et al. 2017; World Health Organisation 2019). Mental and behavioral
disorders affecting more than 25% of all people during their life (Organization 2001). The last
mental health survey of the Iranian adult population by AA Noorbala et al. revealed that 10.39%
of cases were suspected of severe depression (Noorbala et al. 2017). In the present survey, the
prevalence of definite and suspected depression was 17.5% (3% in overweight and 14.3% in
obese patients) and 18.6% (5.9% in overweight and 17.9% in obese patients), respectively, which
is more than that of reported by AA Noorbala (Noorbala et al. 2017). Furthermore, they
demonstrated that about 29.5% of the Iranian population are suspected of anxiety (Noorbala et al.
2017). Based on our results, the prevalence of definite and suspected anxiety was 26.5% (7.4%
in overweight and 19.1% in obese patients) and 22% (5.9% in overweight and 16.1% in obese
patients), respectively. Overall, about 48.5% of the overweight/obese population suffered from
varying degrees of anxiety which is approximately 1.6 times greater than Noorbala et al.’s
estimation (Noorbala et al. 2017). In addition, our data revealed that overweight/obese patients
9
are at greater risk of having a clinical diagnosis of anxiety (r= 0.16, P<0.001) and depressive (r=
0.25, P<0.001).
On the other hand, there is a significant difference in the prevalence of depression between
overweight and obese patients which highlights the tight association of weight status with
depression. While there was not enough evidence to suggest that the prevalence of anxiety
increases in obese patients compared to those who are overweight. It is evident that adults with
current depression or a lifetime diagnosis of depression or anxiety are more likely to be obese
(Strine et al. 2008). Consistently, current data show that the average BMI and PBF were
significantly higher in patients with anxiety and depression. It has been revealed that depression
and anxiety cause obesity as a side-effect of the drugs used to treat them. Additionally, unhealthy
lifestyle, such as insufficient physical exercise and unhealthy diet or increased carbohydrate- and
fat-rich food known as “carbohydrate craving” as a response to enhance brain serotonin synthesis
and alleviating dysphoria possibly leading to obesity (Wurtman and Wurtman 2018).
Neuroendocrine and cortisol disturbances in depressed and anxious patients may be also
Sex differences: In the present study, anxiety but not depression was associated with the female
gender specially housekeepers. It may be caused by more social pressures for being thin on
women rather than men in Iranian people. Some studies have also shown inconsistency regarding
the association between symptoms of anxiety and depression and sex in obese patients (Roberts
and Steele 2010). A community survey in 2003 also indicated that obese women were suffered
more from anxiety than obese men, as well as depressive symptoms which were aligned with
Carpenter et al, and. Palinkas et al, experiences (Jorm et al. 2003; Carpenter et al. 2000). Such
exercise and low familial and social support. However, there were some investigations that have
been also shown no sex differences in obese patients who develop depressive symptoms [20].
Sleep hours: In the present study, sleep hours did not have any significant association with
weight status or HADS scores. Some investigations claimed that sleep disturbances due to
obesity play an important role in psychological function (Whitaker et al. 2018; Koinis-Mitchell
et al. 2017). Current study results were consistent with the existing literature indicating that
obesity; irrespective of changing in sleep hours and gender, positively correlated to anxiety and
depression.
Limitations
The various confounding factors have not been adjusted in this study. Based on a cross-sectional
type of our study, we could not find a transposition correlation between the effects of anxiety and
The existing evidence supported the results are insufficient. Therefore, a longitudinal study with
Conclusions
Findings support the hypothesis that the overweight/obese population are more suspected of
depression and anxiety disorders regardless of sleep status. These findings highlight the
This study was supported by the Trauma Research Center, Tehran Medical Sciences University,
Tehran, Iran. We gratefully acknowledge the dedicated efforts of the investigators, the
11
coordinators, the volunteer patients who participated in this study, and the Clinical Research
Funding
This research received no specific grant from any funding agency in the public, commercial, or
not-for-profit sectors.
References
Beshyah, S. A., C. Freemantle, E. Thomas, and D. Johnston. 1995. Comparison of measurements of body
composition by total body potassium, bioimpedance analysis, and dual-energy X-ray
absorptiometry in hypopituitary adults before and during growth hormone treatment. Am J Clin
Nutr 61 (6):1186-1194.
Bjelland, I., A. A. Dahl, T. T. Haug, and D. Neckelmann. 2002. The validity of the Hospital Anxiety and
Depression Scale: an updated literature review. J Psychosom Res 52 (2):69-77.
Carpenter, K. M., D. S. Hasin, D. B. Allison, and M. S. Faith. 2000. Relationships between obesity and
DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general
population study. Am J Public Health 90 (2):251-257.
Earthman, C. P., J. R. Matthie, P. M. Reid, I. T. Harper, E. Ravussin, and W. H. Howell. 2000. A comparison
of bioimpedance methods for detection of body cell mass change in HIV infection. J Appl Physiol
88 (3):944-956.
Edelstein, B. A., L. W. Drozdick, and C. M. Ciliberti. 2010. Assessment of depression and bereavement in
older adults. In Handbook of Assessment in Clinical Gerontology (Second Edition): Elsevier, 3-43.
Flegal, K. M., B. I. Graubard, D. F. Williamson, and M. H. Gail. 2005. Excess deaths associated with
underweight, overweight, and obesity. Jama 293 (15):1861-1867.
Guedes, E. P., E. Madeira, T. T. Mafort, M. Madeira, R. O. Moreira, L. M. Mendonça, A. F. Godoy-Matos,
A. J. Lopes, and M. L. F. Farias. 2013. Body composition and depressive/anxiety symptoms in
overweight and obese individuals with metabolic syndrome. Diabetol Metab Syndr 5 (1):82.
Jorm, A. F., A. E. Korten, H. Christensen, P. A. Jacomb, B. Rodgers, and R. A. Parslow. 2003. Association of
obesity with anxiety, depression and emotional well-being: a community survey. Aust N Z J
Public Health 27 (4):434-440.
Kalarchian, M. A., and M. D. Marcus. 2012. Psychiatric comorbidity of childhood obesity: Taylor &
Francis.
Labad, J., J. Price, M. Strachan, F. Fowkes, J. Ding, I. Deary, A. Lee, B. Frier, J. Seckl, and B. Walker. 2010.
Edinburgh Type 2 Diabetes Study Investigators: Edinburgh type 2 diabetes study investigators.
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular
disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetologia 53
(3):467-471.
12
Luppino, F. S., L. M. de Wit, P. F. Bouvy, T. Stijnen, P. Cuijpers, B. W. Penninx, and F. G. Zitman. 2010.
Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal
studies. Arch Gen Psychiatry 67 (3):220-229.
Moreira, R. O., K. Marca, J. Appolinario, and W. Coutinho. 2007. Increased waist circumference is
associated with an increased prevalence of mood disorders and depressive symptoms in obese
women. Eat Weight Disord 12 (1):35-40.
Nejat, S., A. Montazeri, K. Holakouie Naieni, K. Mohammad, and S. Majdzadeh. 2006. The World Health
Organization quality of Life (WHOQOL-BREF) questionnaire: Translation and validation study of
the Iranian version. Journal of School of Public Health and Institute of Public Health Research 4
(4):1-12.
Noorbala, A. A., S. Faghihzadeh, K. Kamali, S. A. Bagheri Yazdi, A. Hajebi, M. T. Mousavi, S. Akhondzadeh,
E. Faghihzadeh, and B. Nouri. 2017. Mental Health Survey of the Iranian Adult Population in
2015. Archives of Iranian Medicine (AIM) 20 (3).
Onyike, C. U., R. M. Crum, H. B. Lee, C. G. Lyketsos, and W. W. Eaton. 2003. Is obesity associated with
major depression? Results from the Third National Health and Nutrition Examination Survey. Am
J Epidemiol 158 (12):1139-1147.
Organization, W. H. 2001. Strengthening mental health promotion (fact sheet no. 220). Geneva: WHO.
Pan, A., N. Keum, O. I. Okereke, Q. Sun, M. Kivimaki, R. R. Rubin, and F. B. Hu. 2012. Bidirectional
association between depression and metabolic syndrome: a systematic review and meta-
analysis of epidemiological studies. Diabetes care 35 (5):1171-1180.
Preiss, K., L. Brennan, and D. Clarke. 2013. A systematic review of variables associated with the
relationship between obesity and depression. Obes Rev 14 (11):906-918.
Sturm, R. 2007. Increases in morbid obesity in the USA: 2000–2005. Public health 121 (7):492-496.
Sun, S. S., W. C. Chumlea, S. B. Heymsfield, H. C. Lukaski, D. Schoeller, K. Friedl, R. J. Kuczmarski, K. M.
Flegal, C. L. Johnson, and V. S. Hubbard. 2003. Development of bioelectrical impedance analysis
prediction equations for body composition with the use of a multicomponent model for use in
epidemiologic surveys. Am J Clin Nutr 77 (2):331-340.
Ul-Haq, Z., D. J. Smith, B. I. Nicholl, B. Cullen, D. Martin, J. M. Gill, J. Evans, B. Roberts, I. J. Deary, and J.
Gallacher. 2014. Gender differences in the association between adiposity and probable major
depression: a cross-sectional study of 140,564 UK Biobank participants. BMC psychiatry 14
(1):153.
Whitaker, B. N., P. L. Fisher, S. Jambhekar, G. Com, S. Razzaq, J. E. Thompson, T. G. Nick, and W. L. Ward.
2018. Impact of degree of obesity on sleep, quality of life, and depression in youth. J Pediatr
Health Care 32 (2):e37-e44.
World Health Organisation. 2019 [cited. Available from
https://www.who.int/gho/ncd/risk_factors/overweight_obesity/obesity_adults/en/.
13
(n=194) (n=161)
Variables
* BMI: Body Mass Index, PBF: Percentage body fat, SLM: Soft lean mass
(n=174)
Variables
* BMI: Body Mass Index, PBF: Percentage body fat, SLM: Soft lean mass
y n
Age Coefficient 1
Sig.
Sig. .619
.260** .203**
.116**
Table 4. Mann-Whitney U test for the sex difference in anxiety and depression
Table 5. Kruskal Wallis Test for occupation difference in anxiety and depression
Table 6. Kruskal Wallis Test for BMI categories difference in anxiety and depression
• Body mass index and Percentage body fat were significantly higher among
overweight/obese patients who had anxiety or depression.
Disclosures:
The manuscript has not been and will not be published or submitted elsewhere. The manuscript
has not been published previously (partly or in full), unless the new work concerns an expansion
of previous work. A single study is not split up into several parts to increase the number of
submissions and submitted to various journals or to one journal over time. No data have been
No conflicts of interest have been reported by the authors. Authors whose names appear on the
submission have contributed sufficiently to the scientific work and therefore share collective
responsibility and accountability for the results. All authors have approved the final article
Authorship.
Zahra Alizadeh*
Sports Medicine Research Center, Department of Sports and Exercise Medicine, Tehran
Address: No7, Ale-Ahmad Highway, Opposite of the Shariati Hospital,14395-578, Tehran, Iran